EXHIBIT 15


                    REVIEW REPORT OF INDEPENDENT ACCOUNTANTS





The Board of Directors of
ICN Pharmaceuticals, Inc.

We have reviewed the accompanying consolidated condensed balance sheet of ICN
Pharmaceuticals, Inc. and subsidiaries as of June 30, 1995 and the related
consolidated condensed statements of income for the three and six-month period
ended June 30, 1995 and 1994, and the consolidated condensed statements of cash
flows for the six month periods then ended.  These consolidated condensed
financial statements are the responsibility of the Company's management.

We conducted our review in accordance with standards established by the American
Institute of Certified Public Accountants.  A review of interim financial
information consists principally of applying analytical procedures to financial
data and making inquiries of persons responsible for financial and accounting
matters.  It is substantially less in scope than an audit conducted in
accordance with generally accepted auditing standards, the objective of which is
the expression of an opinion regarding the financial statements taken as a
whole.  Accordingly, we do not express such an opinion.  The Company is a
defendant in various class action lawsuits.  The ultimate outcome of these
lawsuits cannot presently be determined.  Accordingly, no provision for any
liability that may result has been made in the accompanying consolidated
condensed financial statements.

Based on our review, we are not aware of any material modifications that should
be made to be in conformity with generally accepted accounting principles.

We have previously audited, in accordance with generally accepted auditing
standards, the consolidated balance sheet as of December 31, 1994, and the
related consolidated statements of income, shareholders' equity, and cash flows
for the year then ended (not presented herein); and in our report dated February
27, 1995, which included an emphasis of matter paragraph relating to certain
transactions between the Company and previously Affiliated Corporations and an
explanatory paragraph in respect to various class action lawsuits, as more fully
described in the notes to the consolidated financial statements, we expressed an
unqualified opinion on those consolidated financial statements.  In our opinion,
the information set forth in the consolidated condensed balance sheet as of
December 31, 1994, is fairly stated, in all material respects, in relation to
the consolidated balance sheet from which it has been derived.



COOPERS & LYBRAND L.L.P.
Los Angeles, California
July 31, 1995